Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease

Journal of Cardiovascular Magnetic Resonance

Volumn 14, Issue 1, 2012, Pages

  Catalano, Oronzo ^a   Moro, Guido ^a   Perotti, Mariarosa ^a   Frascaroli, Mauro ^a   Ceresa, Monica ^a   Antonaci, Serena ^b   Baiardi, Paola ^a   Napolitano, Carlo ^a,c   Baldi, Maurizia ^a   Priori, Silvia G ^a,d  

^a IRCCS   (Italy)

^b Divisione di Cardiologia   (Italy)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; NITRATE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOBENIC ACID; MEGLUMINE; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MORTALITY; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; RISK ASSESSMENT; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; TIME;

AGED; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; CORONARY ARTERY DISEASE; DISEASE-FREE SURVIVAL; FEMALE; GADOLINIUM DTPA; HEART FAILURE; HOSPITALIZATION; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOMETALLIC COMPOUNDS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE VOLUME; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 84863227579     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-14-29     Document Type: Article

References (14)

1. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM, Circulation 1999 100 1992 2002 10.1161/01.CIR.100.19.1992 10556226 (Pubitemid 29529292)
2. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ, Lancet 2001 357 21 28 10.1016/S0140-6736(00)03567-4 11197356 (Pubitemid 32056497)
3. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ, Judd RM, Circulation 2002 106 2322 2327 10.1161/01.CIR.0000036368. 63317.1C 12403661 (Pubitemid 35244732)
4. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB, Circulation 2006 113 2733 2743 10.1161/CIRCULATIONAHA.105.570648 16754804 (Pubitemid 43947991)
5. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, Boersma E, van der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ, Am J Cardiol 2007 100 930 936 10.1016/j.amjcard.2007.04.029 17826372 (Pubitemid 47368098)
6. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. Kelle S, Roes SD, Klein C, Kokocinski T, de Roos A, Fleck E, Bax JJ, Nagel E, J Am Coll Cardiol 2009 54 1770 1777 10.1016/j.jacc.2009.07.027 19874990
7. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, Schoenhagen P, Starling RC, Flamm SD, Desai MY, JACC Cardiovasc Imaging 2009 2 34 44 10.1016/j.jcmg.2008.09.010 19356530
8. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. Kim HW, Klem I, Shah DJ, Wu E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Kim RJ, PLoS Med 2009 6 1000057 Epub 2009 Apr 21 10.1371/journal.pmed.1000057 19381280
9. Prognostic value of late gadolinium enhancement in hypertensive patients with known or suspected coronary artery disease. Krittayaphong R, Boonyasirinant T, Chaithiraphan V, Maneesai A, Saiviroonporn P, Nakyen S, Thanapiboonpol P, Yindeengam A, Udompanturak S, Int J Cardiovasc Imaging 2010 26 Suppl 1 123 131 20049536
10. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO, Heart 2008 94 730 736 10.1136/hrt.2007.122622 18070953 (Pubitemid 351744690)
11. Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death. van der Burg AE, Bax JJ, Boersma E, Pauwels EK, van der Wall EE, Schalij MJ, Circulation 2003 108 1954 1959 10.1161/01.CIR.0000091410.19963.9A 14530201 (Pubitemid 37303911)
12. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM, N Engl J Med 2000 343 1445 1453 10.1056/NEJM200011163432003 11078769
13. The hibernating myocardium. Rahimtoola SH, Am Heart J 1989 117 211 221 10.1016/0002-8703(89)90685-6 2783527
14. Prediction of global left ventricular functional recovery in patients with heart failure undergoing surgical revascularisation, based on late gadolinium enhancement cardiovascular magnetic resonance. Pegg TJ, Selvanayagam JB, Jennifer J, Francis JM, Karamitsos TD, Dall'Armellina E, Smith KL, Taggart DP, Neubauer S, J Cardiovasc Magn Reson 2010 12 56 10.1186/1532-429X-12-56 20929540